A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Pomalidomide
Related studies linked through entity extraction aliases.
A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- Status
- RECRUITING
- Phase
- PHASE3
Phase II Study of Carfilzomib, Pomalidomide, and Dexamethasone for Myeloma Patients Who Had Relapsed or Progressed After Carfilzomib, Lenalidomide, and Dexamethasone
- Status
- UNKNOWN
- Phase
- PHASE2
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Daratumumab
- Status
- RECRUITING
- Phase
- PHASE3
PVd Versus Vd in NDMM Patients With RI
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL
- Status
- RECRUITING
- Phase
- PHASE2
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma
- Status
- RECRUITING
- Phase
- NA
A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2